Regulus Therapeutics Inc (NASDAQ:RGLS)

Data as of Jan 26
 +0.88 / +4.75%
Today’s Change
Today|||52-Week Range

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year




Operating ActivitiesNet Income / Starting Line-15.6M-7.4M-17.4M-18.7M
Total Other Cash Flow1.1M1.2M5.1M6.0M
Funds From Operations-13.6M-5.3M-9.7M-11.3M
Funds From/For Other Operating Expenses-25.9M9.7M-983.0K17.0M
Net Cash Flow - Operating Activities12.3M-15.1M-8.7M-28.3M
InvestingNet Cash Flow Investing-22.0M3.3M-30.4M-40.9M
FinancingShort Term Borrowings----------
Long Term Borrowings----------
Long Term Debt Reduction----------
Net Proceeds Stock Sale----------
Common Preferred Redeemed----------
Common Dividends----------
Cash Dividends Paid - Total0.
Other Sources - Financing----------
Other Uses - Financing----------
Net Cash Flow - Financing14.7M-354.0K70.5M46.5M
Exchange RateEffect of Exchange Rate on Cash------0.00--
Net Change In Cash5.0M-12.1M31.4M-22.7M

Most stock quote data provided by BATS. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer.

Morningstar: © 2015 Morningstar, Inc. All Rights Reserved.

Factset: FactSet Research Systems Inc. 2015. All rights reserved.

Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved.

Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. Standard & Poor's and S&P are registered trademarks of Standard & Poor’s Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2015 and/or its affiliates.